Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response

International Journal of Cancer

Volumn 129, Issue 3, 2011, Pages 680-690

  Gougelet, Angélique ^a,b   Pissaloux, Daniel ^a   Besse, Anthony ^a   Perez, Jennifer ^a,b   Duc, Adeline ^a,b   Dutour, Aurélie ^a,b   Blay, Jean Yves ^a,b,c   Alberti, Laurent ^a,b  

^a CENTRE LÉON BÉRARD   (France)

^b Conticanet ^*  (Belgium)

^c EORTC DATA CENTER   (Belgium)

Author keywords

chemotherapy; diagnosis; miRNA profiling; osteosarcoma; targeted therapy

Indexed keywords

IFOSFAMIDE; MICRORNA; MICRORNA 132; MICRORNA 193A5P; MICRORNA 422A; MICRORNA 92A; MICRORNA 99B; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DISEASE MODEL; DRUG RESPONSE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROFLUIDIC ANALYSIS; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; IFOSFAMIDE; MICRORNAS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; RATS; TREATMENT OUTCOME;

EID: 79958048319     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25715     Document Type: Article

References (48)

1. He L, Hannon GJ,. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-31. (Pubitemid 38868508)
2. Hutvagner G, Zamore PD,. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002; 297: 2056-60.
3. Lee Y, Jeon K, Lee JT, Kim S, Kim VN,. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002; 21: 4663-70. (Pubitemid 34984353)
4. Doench JG, Sharp PA,. Specificity of microRNA target selection in translational repression. Genes Dev 2004; 18: 504-11. (Pubitemid 38372808)
5. Zhao Y, Srivastava D,. A developmental view of microRNA function. Trends Biochem Sci 2007; 32: 189-97. (Pubitemid 46603281)
6. Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB,. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009; 284: 15676-84.
7. Sugatani T, Hruska KA,. MicroRNA-223 is a key factor in osteoclast differentiation. J Cell Biochem 2007; 101: 996-9. (Pubitemid 47040879)
8. Esquela-Kerscher A, Slack FJ,. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
9. Lu J, Getz G, Miska EA, varez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-8. (Pubitemid 40839735)
10. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61. (Pubitemid 43271657)
11. Israel A, Sharan R, Ruppin E, Galun E,. Increased microRNA activity in human cancers. PLoS One 2009; 4: e6045.
12. Subramanian S, Lui WO, Lee CH, Espinosa I, Nielsen TO, Heinrich MC, Corless CL, Fire AZ, van de RM,. MicroRNA expression signature of human sarcomas. Oncogene 2008; 27: 2015-26. (Pubitemid 351442735)
13. Calin GA, Ferracin M, Cimmino A, Di LG, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-801. (Pubitemid 41549891)
14. Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, Malawer MM,. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 2002; 65: 1123-32.
15. Ferrari S, Palmerini E,. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol 2007; 19: 341-6. (Pubitemid 46883523)
16. Chou AJ, Gorlick R,. Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev Anticancer Ther 2006; 6: 1075-85. (Pubitemid 44203385)
17. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B,. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 2009; 4: e6229.
18. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE,. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112: 55-9.
19. Dutour A, Monteil J, Paraf F, Charissoux JL, Kaletta C, Sauer B, Naujoks K, Rigaud M,. Endostatin cDNA/cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: study in a human-like rat orthotopic tumor. Mol Ther 2005; 11: 311-9.
20. Dutour A, Leclers D, Monteil J, Paraf F, Charissoux JL, Rousseau R, Rigaud M,. Non-invasive imaging correlates with histological and molecular characteristics of an osteosarcoma model: application for early detection and follow-up of MDR phenotype. Anticancer Res 2007; 27: 4171-8.
21. Allouche M, Delbruck HG, Klein B, Masse R, Matar A, Morin M, Lafuma J, Jasmin C,. Malignant bone tumours induced by a local injection of colloidal radioactive 144Cerium in rats as a model for human osteosarcomas. Int J Cancer 1980; 26: 777-82. (Pubitemid 11213233)
22. Arakawa K, Kono N, Yamada Y, Mori H, Tomita M,. KEGG-based pathway visualization tool for complex omics data. In Silico Biol 2005; 5: 419-23. (Pubitemid 41631169)
23. Liu A, Tetzlaff MT, Vanbelle P, Elder D, Feldman M, Tobias JW, Sepulveda AR, Xu X,. MicroRNA Expression Profiling Outperforms mRNA Expression Profiling in Formalin-fixed Paraffin-embedded Tissues. Int J Clin Exp Pathol 2009; 2: 519-27.
24. Linkhart TA, Mohan S, Baylink DJ,. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone 1996; 19: 1S-12S. (Pubitemid 26254474)
25. Franchi A, Arganini L, Baroni G, Calzolari A, Capanna R, Campanacci D, Caldora P, Masi L, Brandi ML, Zampi G,. Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas. J Pathol 1998; 185: 284-9. (Pubitemid 28320050)
26. Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G,. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005; 8: 751-64. (Pubitemid 40585297)
27. Hoang BH, Kubo T, Healey JH, Yang R, Nathan SS, Kolb EA, Mazza B, Meyers PA, Gorlick R,. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res 2004; 64: 2734-9. (Pubitemid 38500609)
28. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008; 68: 6162-70.
29. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-36. (Pubitemid 351185951)
30. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008; 13: 48-57. (Pubitemid 350309743)
31. Fletcher JA, Gebhardt MC, Kozakewich HP,. Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes. Cancer Genet Cytogenet 1994; 77: 81-8. (Pubitemid 24334437)
32. Biegel JA, Womer RB, Emanuel BS,. Complex karyotypes in a series of pediatric osteosarcomas. Cancer Genet Cytogenet 1989; 38: 89-100. (Pubitemid 19124045)
33. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M,. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009; 34: 1069-75.
34. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324: 1710-3.
35. Palmieri A, Pezzetti F, Brunelli G, Martinelli M, Lo ML, Scarano A, Degidi M, Piattelli A, Carinci F,. Peptide-15 changes miRNA expression in osteoblast-like cells. Implant Dent 2008; 17: 100-8.
36. Murata K, Yoshitomi H, Tanida S, Ishikawa M, Nishitani K, Ito H, Nakamura T,. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2010; 12: R86.
37. Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D,. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 2007; 67: 10782-8. (Pubitemid 350145906)
38. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X,. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127: 118-26.
39. Zhu W, Qin W, Atasoy U, Sauter ER,. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2009; 2: 89.
40. Kingsley LA, Fournier PG, Chirgwin JM, Guise TA,. Molecular biology of bone metastasis. Mol Cancer Ther 2007; 6: 2609-17. (Pubitemid 350058141)
41. Mintz MB, Sowers R, Brown KM, Hilmer SC, Mazza B, Huvos AG, Meyers PA, Lafleur B, McDonough WS, Henry MM, Ramsey KE, Antonescu CR, et al. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma. Cancer Res 2005; 65: 1748-54. (Pubitemid 40478600)
42. Salas S, Jezequel P, Campion L, Deville JL, Chibon F, Bartoli C, Gentet JC, Charbonnel C, Gouraud W, Voutsinos-Porche B, Brouchet A, Duffaud F, et al. Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2. Int J Cancer 2009; 125: 851-60.
43. Luksch R, Perotti D, Cefalo G, Gambacorti PC, Massimino M, Spreafico F, Casanova M, Ferrari A, Terenziani M, Polastri D, Gambirasio F, Podda M, et al. Immunomodulation in a treatment program including pre- and post-operative interleukin-2 and chemotherapy for childhood osteosarcoma. Tumori 2003; 89: 263-8. (Pubitemid 37014116)
44. Theoleyre S, Mori K, Cherrier B, Passuti N, Gouin F, Redini F, Heymann D,. Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma. BMC Cancer 2005; 5: 123.
45. Chauvin C, Philippeau JM, Hemont C, Hubert FX, Wittrant Y, Lamoureux F, Trinite B, Heymann D, Redini F, Josien R,. Killer dendritic cells link innate and adaptive immunity against established osteosarcoma in rats. Cancer Res 2008; 68: 9433-40.
46. Mori K, Redini F, Gouin F, Cherrier B, Heymann D,. Osteosarcoma: current status of immunotherapy and future trends (Review). Oncol Rep 2006; 15: 693-700.
47. Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, Jurisica I, Penn LZ, et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest 2009; 89: 597-606.
48. Leite KR, Canavez JM, Reis ST, Tomiyama AH, Piantino CB, Sanudo A, Camara-Lopes LH, Srougi M,. miRNA analysis of prostate cancer by quantitative real time PCR: Comparison between formalin-fixed paraffin embedded and fresh-frozen tissue. Urol Oncol 2009.